Patents by Inventor Ralph Meyer

Ralph Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240009582
    Abstract: A gyroscope includes a frame that surrounds a wheel and a weight that is connected to the wheel. A pair of wheel axles extend from the wheel and connect the wheel to the frame so that the wheel may rotate with respect to the frame. The frame also includes end pivot frames that provide a mounting point for end pivots to be removably attached to the frame. A zip cord may interact with a starting gear on one of the wheel axles to cause rotation of the wheel with respect to the frame.
    Type: Application
    Filed: July 11, 2023
    Publication date: January 11, 2024
    Applicant: Tedco Inc.
    Inventors: Jonathan Patrick Meyer, Ralph Meyer
  • Patent number: 10238453
    Abstract: An endovascular laser treatment device for causing closure of a blood vessel uses an optical fiber adapted to be inserted into a blood vessel. An inner sleeve is arranged around a distal portion of the optical fiber core such that both distal ends of the inner sleeve and the optical fiber core form an enlarged light emitting face. The enlarged emitting face provides substantially lower power density while providing the same amount of total energy during a treatment session. An outer sleeve arranged around the inner sleeve acts as a spacer to position the light emitting face away from an inner wall of the blood vessel. The enlarged light emitting face and the outer sleeve acting as a spacer reduces the possibility of thermal run-away and device damage, and reduce the possibility of vessel perforations, leading to less bruising, post-operative pain and other clinical complications.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: March 26, 2019
    Assignee: AngioDynamics, Inc.
    Inventors: William M. Appling, Ralph A. Meyer, Theodore J. Beyer, William C. Hamilton, Jr., Joe D. Brown
  • Publication number: 20160030113
    Abstract: An endovascular laser treatment device for causing closure of a blood vessel uses an optical fiber adapted to be inserted into a blood vessel. An inner sleeve is arranged around a distal portion of the optical fiber core such that both distal ends of the inner sleeve and the optical fiber core form an enlarged light emitting face. The enlarged emitting face provides substantially lower power density while providing the same amount of total energy during a treatment session. An outer sleeve arranged around the inner sleeve acts as a spacer to position the light emitting face away from an inner wall of the blood vessel. The enlarged light emitting face and the outer sleeve acting as a spacer reduces the possibility of thermal run-away and device damage, and reduce the possibility of vessel perforations, leading to less bruising, post-operative pain and other clinical complications.
    Type: Application
    Filed: October 15, 2015
    Publication date: February 4, 2016
    Inventors: William M. Appling, Ralph A. Meyer, Theodore J. Beyer, William C. Hamilton, JR., Joe D. Brown
  • Publication number: 20150025512
    Abstract: An endovascular laser treatment device for causing closure of a blood vessel uses an optical fiber adapted to be inserted into a blood vessel. An inner sleeve is arranged around a distal portion of the optical fiber core such that both distal ends of the inner sleeve and the optical fiber core form an enlarged light emitting face. The enlarged emitting face provides substantially lower power density while providing the same amount of total energy during a treatment session. An outer sleeve arranged around the inner sleeve acts as a spacer to position the light emitting face away from an inner wall of the blood vessel. The enlarged light emitting face and the outer sleeve acting as a spacer reduces the possibility of thermal run-away and device damage, and reduce the possibility of vessel perforations, leading to less bruising, post-operative pain and other clinical complications.
    Type: Application
    Filed: September 12, 2014
    Publication date: January 22, 2015
    Inventors: William M. Appling, Ralph A. Meyer, Theodore J. Beyer, William C. Hamilton, Jr., Joe D. Brown
  • Patent number: 8864755
    Abstract: An endovascular treatment method for causing closure of a blood vessel is provided. The method includes inserting into a blood vessel an optical fiber having a core through which a laser light travels and a spacer sleeve arranged around a distal portion of the core. A distal end of the core defines an enlarged light emitting face, which advantageously provides substantially lower power density while providing the same amount of total energy during a treatment session. After the insertion, laser light is applied through the light emitting face while the inserted optical fiber and spacer sleeve are longitudinally moved. The spacer sleeve positions the light emitting face away from an inner wall of the blood vessel and application of the laser light causes closure of the blood vessel.
    Type: Grant
    Filed: August 3, 2012
    Date of Patent: October 21, 2014
    Assignee: AngioDynamics, Inc.
    Inventors: William M. Appling, Ralph A. Meyer, Theodore J. Beyer, William C. Hamilton, Jr., Joe D. Brown
  • Patent number: 8864754
    Abstract: An endovascular laser treatment device for causing closure of a blood vessel uses an optical fiber adapted to be inserted into a blood vessel. An inner sleeve is arranged around a distal portion of the optical fiber core such that both distal ends of the inner sleeve and the optical fiber core form an enlarged light emitting face. The enlarged emitting face provides substantially lower power density while providing the same amount of total energy during a treatment session. An outer sleeve arranged around the inner sleeve acts as a spacer to position the light emitting face away from an inner wall of the blood vessel. The enlarged light emitting face and the outer sleeve acting as a spacer reduces the possibility of thermal run-away and device damage, and reduce the possibility of vessel perforations, leading to less bruising, post-operative pain and other clinical complications.
    Type: Grant
    Filed: April 9, 2008
    Date of Patent: October 21, 2014
    Assignee: AngioDynamics, Inc.
    Inventors: William M. Appling, Ralph A. Meyer, Theodore J. Beyer, William C. Hamilton, Jr., Joe D. Brown
  • Publication number: 20140186311
    Abstract: The invention relates to a method for transiently immortalizing cells according to which immortalization proteins are introduced into the cells from outside. The invention also relates to a method for producing cells according to which organ-related cells are transiently immortalized by the exogenous supply of immortalization proteins and are remortalized after their expansion. The invention further relates to the cells produced according to the inventive method, to the use of said cells for producing a transplant and to the immortalization proteins used in the method.
    Type: Application
    Filed: January 21, 2014
    Publication date: July 3, 2014
    Applicant: HEART BIOSYSTEMS GMBH
    Inventors: Jan-Heiner Kupper, Ralph Meyer, Mirella Meyer-Ficca, Anne Kuhn
  • Patent number: 8568972
    Abstract: A DNA construct is described which contains a fusion gene under the control of a promoter. The fusion gene comprises at least one resistance gene and at least one reporter gene and is slightly toxic to a host cell transfected with that DNA construct. That DNA construct can be encoded on a plasmid or a virus. Further, a method is described for using the DNA construct to identify substances that may cause a differentiation in eukaryotic cells.
    Type: Grant
    Filed: July 6, 2009
    Date of Patent: October 29, 2013
    Assignee: Medicyte GmbH
    Inventors: Jan-Heiner Kuepper, Reinhard Kandolf, Ralph Meyer
  • Publication number: 20130035287
    Abstract: The invention relates to a method for transiently immortalizing cells according to which immortalization proteins are introduced into the cells from outside. The invention also relates to a method for producing cells according to which organ-related cells are transiently immortalized by the exogenous supply of immortalization proteins and are remortalized after their expansion. The invention further relates to the cells produced according to the inventive method, to the use of said cells for producing a transplant and to the immortalization proteins used in the method.
    Type: Application
    Filed: June 22, 2012
    Publication date: February 7, 2013
    Applicant: HEART BIOSYSTEMS GMBH
    Inventors: Jan-Heiner Kupper, Ralph Meyer, Mirella Meyer-Ficca, Anne Kuhn
  • Publication number: 20120316546
    Abstract: An endovascular treatment method for causing closure of a blood vessel is provided. The method includes inserting into a blood vessel an optical fiber having a core through which a laser light travels and a spacer sleeve arranged around a distal portion of the core. A distal end of the core defines an enlarged light emitting face, which advantageously provides substantially lower power density while providing the same amount of total energy during a treatment session. After the insertion, laser light is applied through the light emitting face while the inserted optical fiber and spacer sleeve are longitudinally moved. The spacer sleeve positions the light emitting face away from an inner wall of the blood vessel and application of the laser light causes closure of the blood vessel.
    Type: Application
    Filed: August 3, 2012
    Publication date: December 13, 2012
    Inventors: William M. Appling, Ralph A. Meyer, Theodore J. Beyer, William C. Hamilton, JR., Joe D. Brown
  • Publication number: 20090291429
    Abstract: A DNA construct is described which contains a fusion gene under the control of a promoter. The fusion gene comprises at least one resistance gene and at least one reporter gene and is slightly toxic to a host cell transfected with that DNA construct. That DNA construct can be encoded on a plasmid or a virus. Further, a method is described for using the DNA construct to identify substances that may cause a differentiation in eukaryotic cells.
    Type: Application
    Filed: July 6, 2009
    Publication date: November 26, 2009
    Inventors: Jan-Heiner KUEPPER, Reinhard KANDOLF, Ralph MEYER
  • Publication number: 20090131924
    Abstract: An endovenous thermal treatment device in which a thermal energy delivery device can be inserted into a blood vessel without the use of a treatment sheath is provided. The treatment device includes a carrier wire having a flexible distal section and a longitudinal energy delivery device having a distal energy emitting section. A coupler couples the carrier wire and the energy delivery device so that they are inserted together into a blood vessel.
    Type: Application
    Filed: November 14, 2008
    Publication date: May 21, 2009
    Inventors: Ralph A. Meyer, William M. Appling
  • Publication number: 20080287939
    Abstract: An elongated thermal energy delivery device for use in endovenous thermal treatment of blood vessel is provided. The energy device includes a flexible guide tip attached to its distal portion which provides for direct tracking and advancement of the energy device through the vein without the use of a treatment sheath. Also provided is a method of using the thermal energy delivery device with flexible guide tip. The method eliminates the need for a treatment sheath and accessory procedural components and the procedural steps associated with these components.
    Type: Application
    Filed: June 30, 2008
    Publication date: November 20, 2008
    Inventors: William M. Appling, Ralph A. MEYER, Leonard G. Schaefer
  • Publication number: 20080221058
    Abstract: The invention relates to a vector for the gene therapeutic treatment of tumors, especially in connection with radiotherapy. Said vector is provided with a therapeutic gene in the DNA sequence thereof. The gene is controlled by the promoter for the catalytic subunit of the telomerase or by the promoter for cyclin A.
    Type: Application
    Filed: February 13, 2008
    Publication date: September 11, 2008
    Inventors: Jan-Heinerr Kupper, Ralph Meyer, Mirella Meyer-Ficca, Reinhard Kandolf
  • Publication number: 20080188843
    Abstract: An endovascular laser treatment device for causing closure of a blood vessel uses an optical fiber adapted to be inserted into a blood vessel. An inner sleeve is arranged around a distal portion of the optical fiber core such that both distal ends of the inner sleeve and the optical fiber core form an enlarged light emitting face. The enlarged emitting face provides substantially lower power density while providing the same amount of total energy during a treatment session. An outer sleeve arranged around the inner sleeve acts as a spacer to position the light emitting face away from an inner wall of the blood vessel. The enlarged light emitting face and the outer sleeve acting as a spacer reduces the possibility of thermal run-away and device damage, and reduce the possibility of vessel perforations, leading to less bruising, post-operative pain and other clinical complications.
    Type: Application
    Filed: April 9, 2008
    Publication date: August 7, 2008
    Inventors: William M. Appling, Ralph A. Meyer, Theodore J. Beyer, William C. Hamilton, Joe D. Brown
  • Patent number: 7351697
    Abstract: The invention relates to a vector for the gene therapeutic treatment of tumors, especially in connection with radiotherapy. Said vector is provided with a therapeutic gene in the DNA sequence thereof. The gene is controlled by the promoter for the catalytic subunit of the telomerase or by the promoter for cyclin A.
    Type: Grant
    Filed: July 21, 2005
    Date of Patent: April 1, 2008
    Inventors: Jan-Heinerr Küpper, Ralph Meyer, Mirella Meyer-Ficca, Reinhard Kandolf
  • Publication number: 20070237754
    Abstract: The invention relates to a method for transiently immortalizing cells according to which immortalization proteins are introduced into the cells from outside. The invention also relates to a method for producing cells according to which organ-related cells are transiently immortalized by the exogenous supply of immortalization proteins and are remortalized after their expansion. The invention further relates to the cells produced according to the inventive method, to the use of said cells for producing a transplant and to the immortalization proteins used in the method.
    Type: Application
    Filed: May 21, 2007
    Publication date: October 11, 2007
    Inventors: Jan-Heiner Kupper, Ralph Meyer, Mirella Meyer-Ficca, Anne Kuhn
  • Publication number: 20070025971
    Abstract: A DNA construct is described which contains a fusion gene under the control of a promoter. The fusion gene comprises at least one resistance gene and at least one reporter gene and is slightly toxic to a host cell transfected with that DNA construct. That DNA construct can be encoded on a plasmid or a virus. Further, a method is described for using the DNA construct to identify substances that may cause a differentiation in eukaryotic cells.
    Type: Application
    Filed: July 27, 2006
    Publication date: February 1, 2007
    Inventors: Jan-Heiner Kuepper, Reinhard Kandolf, Ralph Meyer
  • Patent number: D976982
    Type: Grant
    Filed: May 20, 2019
    Date of Patent: January 31, 2023
    Assignee: NICO CORPORATION
    Inventor: Ralph A. Meyer
  • Patent number: D1035735
    Type: Grant
    Filed: December 13, 2022
    Date of Patent: July 16, 2024
    Assignee: NICO CORPORATION
    Inventor: Ralph A. Meyer